UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 152

Sortiert nach

Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma

PloS one, 2020-08, Vol.15 (8), p.e0238251-e0238251

2020

Volltextzugriff (PDF)

Long‐term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B

Hepatology (Baltimore, Md.), 2010-09, Vol.52 (3), p.886-893

2010

Volltextzugriff (PDF)

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen–positive chronic hepatitis B

Hepatology (Baltimore, Md.), 2010-02, Vol.51 (2), p.422-430

2010

Volltextzugriff (PDF)

Long‐term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B

Hepatology (Baltimore, Md.), 2008-09, Vol.48 (3), p.750-758

2008

Volltextzugriff (PDF)

Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease

Hepatology (Baltimore, Md.), 2011-01, Vol.53 (1), p.62-72

2011

Volltextzugriff (PDF)

Urine DNA biomarkers for hepatocellular carcinoma screening

British journal of cancer, 2022-06, Vol.126 (10), p.1432-1438

2022

Volltextzugriff (PDF)

Telbivudine on IgG-associated hypergammaglobulinemia and TGF-β1 hyperactivity in hepatitis B virus-related liver cirrhosis

PloS one, 2019-11, Vol.14 (11), p.e0225482-e0225482

2019

Volltextzugriff (PDF)

A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B

The New England journal of medicine, 2006-03, Vol.354 (10), p.1001-1010

2006

Volltextzugriff (PDF)

Novel urine cell-free DNA methylation markers for hepatocellular carcinoma

Scientific reports, 2023-12, Vol.13 (1), p.21585-21585, Article 21585

2023

Volltextzugriff (PDF)

Applications of next-generation sequencing analysis for the detection of hepatocellular carcinoma-associated hepatitis B virus mutations

Journal of biomedical science, 2018-06, Vol.25 (1), p.51-12, Article 51

2018

Volltextzugriff (PDF)

Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program

Hepatology (Baltimore, Md.), 2015-06, Vol.61 (6), p.1870-1879

2015

Volltextzugriff (PDF)

Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV

PloS one, 2021-05, Vol.16 (5), p.e0251552-e0251552

2021

Volltextzugriff (PDF)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

BMC infectious diseases, 2022-04, Vol.22 (1), p.351-9, Article 351

2022

Volltextzugriff (PDF)

Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines

Hepatology international, 2021-12, Vol.15 (6), p.1421-1430

2021

Volltextzugriff (PDF)

Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients

Frontiers in immunology, 2017-05, Vol.8, p.621-621

2017

Volltextzugriff (PDF)

The Impact of Type 2 Diabetes on the Development of Hepatocellular Carcinoma in Different Viral Hepatitis Statuses

Cancer epidemiology, biomarkers & prevention, 2009-07, Vol.18 (7), p.2054-2060

2009

Volltextzugriff (PDF)

The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients

Viruses, 2022-08, Vol.14 (8), p.1812

2022

Volltextzugriff (PDF)

Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines

Hepatology international, 2024-06, Vol.18 (3), p.1066-1066

2024

Volltextzugriff (PDF)

Herbal and dietary supplement-induced liver injury in Taiwan: comparison with conventional drug-induced liver injury

Hepatology international, 2021-12, Vol.15 (6), p.1456-1465

2021

Volltextzugriff (PDF)

Hepatitis C Virus Infection and the Development of Type 2 Diabetes in a Community-based Longitudinal Study

American journal of epidemiology, 2007-07, Vol.166 (2), p.196-203

2007

Volltextzugriff (PDF)

Hepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinoma

PloS one, 2012-07, Vol.7 (7), p.e41931-e41931

2012

Volltextzugriff (PDF)

Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation

Cellular microbiology, 2017-04, Vol.19 (4), p.np-n/a

2017

Volltextzugriff (PDF)

Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma

PloS one, 2013-11, Vol.8 (11), p.e80053-e80053

2013

Volltextzugriff (PDF)

The B56γ3-containing protein phosphatase 2A attenuates p70S6K-mediated negative feedback loop to enhance AKT-facilitated epithelial-mesenchymal transition in colorectal cancer

Cell communication and signaling, 2023-07, Vol.21 (1), p.172-172, Article 172

2023

Volltextzugriff (PDF)

Fucosyl-Agalactosyl IgG₁ Induces Cholangiocarcinoma Metastasis and Early Recurrence by Activating Tumor-Associated Macrophage

Cancers, 2018-11, Vol.10 (11), p.460

2018

Volltextzugriff (PDF)

1 – 25 von 152

Suche als RSS-Feed

Aktive Filter

KollektionEZB Electronic Journals Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(140)
Mit Volltextzugriff
(149)

Publikationsform

Artikel
(151)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(113)
Life Sciences & Biomedicine
(94)
Humans
(86)
Male
(59)
Female
(58)
Middle Aged
(50)
Adult
(46)
Aged
(34)
Gastroenterology & Hepatology
(34)
Hepatitis B
(34)
Hepatitis B Virus
(34)
Hepatitis
(33)
Biological And Medical Sciences
(31)
Infectious Diseases
(31)
Medical Sciences
(31)
Hepatocellular Carcinoma
(29)
Hepatitis B Virus - Genetics
(26)
Antiviral Agents - Therapeutic Use
(23)
Dna
(23)
Hepatitis B, Chronic - Drug Therapy
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma

Long‐term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen–positive chronic hepatitis B

Long‐term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B

Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease

Urine DNA biomarkers for hepatocellular carcinoma screening

Telbivudine on IgG-associated hypergammaglobulinemia and TGF-β1 hyperactivity in hepatitis B virus-related liver cirrhosis

A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B

Novel urine cell-free DNA methylation markers for hepatocellular carcinoma

Applications of next-generation sequencing analysis for the detection of hepatocellular carcinoma-associated hepatitis B virus mutations

Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program

Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines

Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients

The Impact of Type 2 Diabetes on the Development of Hepatocellular Carcinoma in Different Viral Hepatitis Statuses

The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients

Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines

Herbal and dietary supplement-induced liver injury in Taiwan: comparison with conventional drug-induced liver injury

Hepatitis C Virus Infection and the Development of Type 2 Diabetes in a Community-based Longitudinal Study

Hepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinoma

Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation

Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma

The B56γ3-containing protein phosphatase 2A attenuates p70S6K-mediated negative feedback loop to enhance AKT-facilitated epithelial-mesenchymal transition in colorectal cancer

Fucosyl-Agalactosyl IgG₁ Induces Cholangiocarcinoma Metastasis and Early Recurrence by Activating Tumor-Associated Macrophage

Aktive Filter

Suchergebnisse filtern